🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Boston Scientific Corporation

BSX Healthcare
$43.87 $-1.18 (-2.62%)
Market Cap: $63.58 B
Gurus Holding
17
Popularity Rank
#72
% of Shares Held
1.54%
Net Activity (Q2 2026)
+$119.69 M

Guru Ownership Trend

Guru Analysis for Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 17 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $978.4 M.

Top institutional holders include Cliff Asness and Lee Ainslie.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $119.69 M net inflow during the quarter.

Recent activity highlights Ray Dalio who increased their stake by 474.1%. Conversely, Jefferies Group reduced exposure by 93.6%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$359.87 M
Total Buy Value
New Buys 4
Additions 6
-$240.18 M
Total Sell Value
Reductions 7
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
9
Net Buyers
10

FAQs for Boston Scientific Corporation (BSX)

Major holders include Cliff Asness ($413.22 M), Lee Ainslie ($253.41 M), Renaissance Technologies (RenTech) ($102.94 M). According to the latest reported data, 17 tracked investment managers collectively hold approximately 22.3 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $119.69 M, with 10 managers increasing positions and 9 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 2 fully exited BSX. The total reported sell value was $240.18 M.

Yes, 4 managers opened new positions in BSX, and 6 increased their existing holdings. The total reported buy value was $359.87 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% Add 84.8% 9,681,750 $413.22 M Q2 2026
2.24% Add 41.5% 5,937,553 $253.41 M Q2 2026
0.14% Reduce -23.5% 2,412,005 $102.94 M Q2 2026
0.09% Add 133.6% 1,477,637 $63.07 M Q2 2026
0.33% New Buy 720,339 $30.74 M Q2 2026
0.08% Add 474.1% 442,036 $18.87 M Q2 2026
0.04% Reduce -22.4% 374,708 $15.99 M Q2 2026
0.02% Reduce -90.1% 365,241 $15.59 M Q2 2026
0.00% Reduce -26.0% 333,528 $14.24 M Q2 2026
0.12% New Buy 189,256 $8.08 M Q2 2026
0.05% Add 5.1% 157,829 $6.74 M Q2 2026
0.09% New Buy 113,096 $4.83 M Q2 2026
0.02% Reduce -58.4% 64,563 $2.76 M Q2 2026
0.00% Add 45.3% 21,800 $930,424 Q2 2026
0.00% Reduce -2.6% 9,914 $423,130 Q2 2026
0.00% Reduce -93.6% 896 $38,242 Q2 2026
0.00% New Buy 100 $4,348 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form